Q2 2023 · 13F-HR
Alphabet Inc. (GOOG, GOOGL)holdings as filed
Filed 2023-08-04 · accession 0001652044-23-000075
$1.86B
Reported value
47
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 90364P105 | PATH | UiPath Inc | $233.1M | 12.5% | 14,068,674 | Common | SHARED |
| 92539P101 | — | Verve Therapeutics Inc. | $197.8M | 10.6% | 10,549,086 | Common | SHARED |
| 687793109 | OSCR | Oscar Health Inc. | $193.8M | 10.4% | 24,042,864 | Common | SHARED |
| 22788C105 | CRWD | Crowdstrike Hldgs Inc | $188.5M | 10.1% | 1,283,683 | Common | SHARED |
| 74168J101 | PRME | Prime Medicine, Inc. | $173.8M | 9.34% | 11,862,498 | Common | SHARED |
| 252131107 | DXCM | Dexcom Inc | $155.9M | 8.37% | 1,212,806 | Common | SHARED |
| 37637K108 | GTLB | Gitlab Inc. | $135.3M | 7.27% | 2,647,312 | Common | SHARED |
| 72703X106 | PL | Planet Labs Inc. | $102.9M | 5.53% | 31,942,641 | Common | SHARED |
| 833445109 | SNOW | Snowflake Inc | $94.3M | 5.06% | 535,604 | Common | SHARED |
| 26886C107 | — | EQRX Inc | $88.7M | 4.76% | 47,675,476 | Common | SHARED |
| 358054104 | FRSH | Freshworks Inc | $70.9M | 3.81% | 4,035,595 | Common | SHARED |
| 55087P104 | LYFT | Lyft Inc | $35.5M | 1.91% | 3,702,054 | Common | SHARED |
| 082490103 | — | Benson Hill Inc. | $20.0M | 1.07% | 15,352,271 | Common | SHARED |
| 75943R102 | RLAY | Relay Therapeutics Inc. | $19.7M | 1.06% | 1,568,753 | Common | SHARED |
| 25058X105 | — | Desktop Metal Inc. | $19.6M | 1.05% | 11,048,730 | Common | SHARED |
| 55083R104 | — | Lyell Immunopharma Inc. | $18.7M | 1.00% | 5,865,125 | Common | SHARED |
| 799566104 | SANA | Sana Biotechnology Inc. | $16.8M | 0.90% | 2,812,500 | Common | SHARED |
| 07373V105 | BEAM | Beam Therapeutics Inc. | $10.3M | 0.55% | 321,604 | Common | SHARED |
| 75382E109 | — | RAPT Therapeutics Inc. | $10.1M | 0.54% | 540,270 | Common | SHARED |
| 61225M102 | GLUE | Monte Rosa Therapeutics Inc. | $10.0M | 0.54% | 1,464,015 | Common | SHARED |
| 452327109 | ILMN | Illumina Inc. | $10.0M | 0.54% | 53,470 | Common | SHARED |
| 24343R106 | — | Decibel Therapeutics Inc. | $6.3M | 0.34% | 1,636,258 | Common | SHARED |
| 770700102 | HOOD | Robinhood Mkts Inc | $6.1M | 0.33% | 612,214 | Common | SHARED |
| 00534A102 | IVVD | Invivyd Inc. | $6.0M | 0.32% | 5,680,785 | Common | SHARED |
| 87990A106 | TNYA | Tenaya Therapeutics Inc. | $5.4M | 0.29% | 915,705 | Common | SHARED |
| 92337R101 | VERA | Vera Therapeutics Inc. | $4.8M | 0.26% | 301,580 | Common | SHARED |
| 344174107 | FHTX | Foghorn Therapeutics Inc. | $3.5M | 0.19% | 500,901 | Common | SHARED |
| 91864C107 | BRNS | Vaccitech PLC | $3.1M | 0.17% | 1,513,644 | Common | SHARED |
| 89854M101 | TCRX | Tscan Therapeutics Inc. | $2.7M | 0.14% | 1,077,080 | Common | SHARED |
| 55910K108 | — | Magenta Therapeutics Inc. | $2.5M | 0.14% | 3,339,138 | Common | SHARED |
| 50107A104 | KRON1USD | Kronos Bio Inc. | $2.5M | 0.13% | 1,438,232 | Common | SHARED |
| 30063P105 | EXK | Exact Sciences Corp | $2.2M | 0.12% | 23,205 | Common | SHARED |
| 44916K106 | HYPR | Hyperfine Inc. | $1.9M | 0.10% | 898,720 | Common | SHARED |
| 753018100 | RANI | Rani Therapeutics Hldgs Inc. | $1.8M | 0.10% | 448,492 | Common | SHARED |
| 05280R100 | AUTL | Autolus Therapeutics PLC | $1.7M | 0.09% | 698,262 | Common | SHARED |
| 84833T103 | SPRO | Spero Therapeutics Inc. | $1.3M | 0.07% | 889,979 | Common | SHARED |
| 014442107 | ALEC | Alector Inc. | $1.1M | 0.06% | 175,866 | Common | SHARED |
| 808644108 | — | Science 37 Holdings Inc. | $673,524 | 0.04% | 3,207,260 | Common | SHARED |
| 68376D104 | OPRT | Oportun Finl Corp | $565,884 | 0.03% | 94,788 | Common | SHARED |
| 877619106 | TSHA | Taysha Gene Therapies Inc. | $422,982 | 0.02% | 640,882 | Common | SHARED |
| 22053A107 | — | Quince Therapeutics Inc | $285,574 | 0.02% | 189,122 | Common | SHARED |
| 46185L103 | NVTA1EUR | Invitae Corp | $266,235 | 0.01% | 235,606 | Common | SHARED |
| 299734202 | EVLO | Evelo Biosciences Inc. | $172,328 | 0.01% | 53,024 | Common | SHARED |
| 465712107 | MOND | Mondee Holdings Inc. | $164,122 | 0.01% | 18,420 | Common | SHARED |
| 759916109 | RGEN | Repligen Corp | $54,179 | 0.00% | 383 | Common | SHARED |
| 359616109 | FULC | Fulcrum Therapeutics Inc | $47,065 | 0.00% | 14,262 | Common | SHARED |
| 229790100 | HLTHQ | Cue Health Inc | $9,990 | 0.00% | 27,000 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.